Grantham, Mayo, Van Otterloo & Co (GMO)
SEM

Grantham, Mayo, Van Otterloo & Co (GMO)’s Select Medical SEM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-986,809
Closed -$16.1M – 715
2026
Q1 		$16.1M Buy
+986,809
New +$15.4M 0.04% 204
2023
Q2 		– Sell
-27,469
Closed -$383K – 740
2023
Q1 		$383K Sell
27,469
-8,909
-24% -$131K ﹤0.01% 591
2022
Q4 		$487K Sell
36,378
-18,931
-34% -$245K ﹤0.01% 580
2022
Q3 		$659K Sell
55,309
-144,768
-72% -$2.06M ﹤0.01% 547
2022
Q2 		$2.55M Sell
200,077
-32,480
-14% -$417K 0.01% 419
2022
Q1 		$3.01M Buy
+232,557
New +$3.07M 0.01% 405
2021
Q4 		– Sell
-82,406
Closed -$1.61M – 730
2021
Q3 		$1.61M Buy
82,406
+71,827
+679% +$1.43M 0.01% 485
2021
Q2 		$241K Sell
10,579
-56,296
-84% -$1.17M ﹤0.01% 685
2021
Q1 		$1.23M Sell
66,875
-255,141
-79% -$4.18M 0.01% 560
2020
Q4 		$4.8M Sell
322,016
-113,958
-26% -$1.49M 0.03% 297
2020
Q3 		$4.89M Buy
435,974
+57,536
+15% +$567K 0.03% 242
2020
Q2 		$3M Buy
378,438
+45,472
+14% +$377K 0.02% 337
2020
Q1 		$2.69M Buy
+332,966
New +$3.96M 0.02% 344
2018
Q3 		– Sell
-48,256
Closed -$472K – 580
2018
Q2 		$472K Sell
48,256
-23,571
-33% -$231K ﹤0.01% 473
2018
Q1 		$668K Hold
71,827
– – ﹤0.01% 428
2017
Q4 		$683K Buy
+71,827
New +$686K ﹤0.01% 409

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SEM Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Select Medical (SEM) in Q2 2026, closing a stake of 986,809 shares — an estimated $16.1M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SEM in Q4 2017 and held it in 16 quarters. The position peaked at $16.1M in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 986,809 Select Medical shares in Q2 2026, an estimated $16.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Select Medical in Q4 2017 and held it in 16 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Select Medical position peaked at $16.1M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.